Inactive Instrument
Aoxing Pharmaceutical Company, Inc. Share Price Other OTC
Stocks
AOXG
US03740A1060
Professional & Business Education
OTC Markets Traded| Market Cap | 23.62M 20.71M 19.09M 17.88M 33.52M 2.23B 34.22M 229M 88.8M 1.1B 88.71M 86.77M 3.82B | P/E 2015 |
20.1x | P/E 2016 | 23.2x |
|---|---|---|---|---|---|
| Enterprise Value | 42.18M 36.99M 34.09M 31.92M 59.85M 3.98B 61.1M 410M 159M 1.97B 158M 155M 6.82B | EV / Sales 2015 |
5.77x | EV / Sales 2016 | 2.11x |
| Free-Float |
100% | Yield 2015 * |
-
| Yield 2016 | - |
| 1 day | -20.71% |
| Manager | Title | Age | Since |
|---|---|---|---|
Chun Fai Lo
CEO | Chief Executive Officer | - | - |
Po Chim
DFI | Director of Finance/CFO | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -20.71% | -19.80% | - | - | 1.56M | |
| +3.92% | +3.07% | +24.60% | +530.15% | 2.29B | |
| -3.71% | -0.69% | - | - | 1.88B | |
| -1.64% | -5.26% | -39.60% | -62.03% | 1.63B | |
| +1.84% | +3.01% | +116.91% | +675.89% | 1.58B | |
| -2.49% | -3.97% | +275.46% | +859.55% | 1.06B | |
| -2.12% | -9.09% | -45.10% | +15.99% | 1.05B | |
| +5.01% | -2.75% | +78.96% | +84.80% | 975M | |
| -0.24% | -0.95% | +54.02% | +48.78% | 951M | |
| +0.47% | -16.02% | -40.93% | -90.05% | 413M | |
| Average | -1.97% | -3.24% | +53.04% | +257.89% | 1.31B | |
| Weighted average by Cap. | +0.19% | -1.63% | +53.50% | +321.65% |
| 2015 | 2016 | |
|---|---|---|
| Net sales | 25.48M 22.34M 20.59M 19.28M 36.15M 2.4B 36.9M 248M 95.78M 1.19B 95.68M 93.59M 4.12B | 32.33M 28.35M 26.13M 24.46M 45.87M 3.05B 46.82M 314M 122M 1.51B 121M 119M 5.23B |
| Net income | 5.49M 4.82M 4.44M 4.16M 7.8M 518M 7.96M 53.38M 20.65M 256M 20.63M 20.18M 888M | 2.06M 1.81M 1.67M 1.56M 2.92M 194M 2.99M 20.02M 7.75M 96.1M 7.74M 7.57M 333M |
| Net Debt | 24.8M 21.75M 20.05M 18.77M 35.19M 2.34B 35.92M 241M 93.23M 1.16B 93.14M 91.11M 4.01B | 18.56M 16.27M 15M 14.04M 26.33M 1.75B 26.88M 180M 69.76M 865M 69.69M 68.17M 3B |
Employees
-
